Skip to main content
Erschienen in: Head and Neck Pathology 1/2021

02.06.2020 | Case Reports

Signet Ring Cell Differentiation in Salivary Duct Carcinoma with Rhabdoid Features: Report of Three Cases and Literature Review

verfasst von: Mayumi Akaki, Akira Ishihara, Kentaro Nagai, Hidekazu Naono, Kenichi Taguchi, Hidetaka Yamamoto, Hiroyuki Tanaka, Hiroaki Kataoka

Erschienen in: Head and Neck Pathology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Salivary duct carcinoma with rhabdoid features (SDCRF) is a rare salivary tumor with poor prognosis and is proposed as a salivary counterpart of pleomorphic lobular carcinoma of the breast (PLCB). Here, we report three cases of SDC with rhabdoid features (SDCRF) mimicking PLCB. Pleomorphic adenoma (PA) component was accompanied in all the cases confirming carcinoma ex PA. One patient had frequent rhabdoid features and showed invasive growth into the surrounding tissue. The other two patients had intracapsular tumor but with rhabdoid features. The patients with intracapsular SDCRF survived for > 5 years after surgery with no evidence of recurrence, whereas the patient with extracapsular SDCRF died 10 months after biopsy, and autopsy revealed disseminated metastasis to the central nervous system. Histologically, tumor cells in all three cases resembled PLCB, with a discohesive appearance, abundant cytoplasm, enlarged hyperchromatic nuclei, and similar immunohistochemical profiles, namely loss of membranous E-cadherin, obscured expression of membranous β-catenin, diffuse positivity of androgen receptor, gross cystic disease fluid protein-15, mitochondrial adenosine triphosphate synthase subunit β, MUC1, and INI-1. Estrogen and progesterone receptors were negative, and HER2 immunoreactivities were variable. The tumor cells of extracapsular invasive SDCRF exhibited higher MIB-1 labeling index and more frequent intracytoplasmic lumina than those of intracapsular SDCRF. Ultrastructurally, rhabdoid cells contained intracytoplasmic lumina with microvillous structure, analogous to those reported in PLCB. No intracytoplasmic intermediate filament aggregation was observed. These observations indicate that SDCRF is a salivary counterpart of PLCB and under signet ring cell differentiation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Nagao T, Licitra L, Loening T, Vielh P, Williams MD. Salivary duct carcinoma. In: El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. Lyon: International Agency for Research on Cancer; 2017. p. 173–174. Nagao T, Licitra L, Loening T, Vielh P, Williams MD. Salivary duct carcinoma. In: El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. Lyon: International Agency for Research on Cancer; 2017. p. 173–174.
2.
Zurück zum Zitat Williams MD, Ihrler S, Seethala R. Carcinoma ex pleomorphic adenoma. In: El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. Lyon: International Agency for Research on Cancer; 2017. p. 176–177. Williams MD, Ihrler S, Seethala R. Carcinoma ex pleomorphic adenoma. In: El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. Lyon: International Agency for Research on Cancer; 2017. p. 176–177.
3.
Zurück zum Zitat Shin S, Desmedt C, Kristiansen G, Reis-Fiho J, Sasano H. Invasive lobular carcinoma. In: Lokuhetty D, White V, Watanabe R, Cree I, editors. WHO classification of tumours breast tumours. Lyon: International Agency for Research on Cancer; 2019. p. 114–118. Shin S, Desmedt C, Kristiansen G, Reis-Fiho J, Sasano H. Invasive lobular carcinoma. In: Lokuhetty D, White V, Watanabe R, Cree I, editors. WHO classification of tumours breast tumours. Lyon: International Agency for Research on Cancer; 2019. p. 114–118.
6.
Zurück zum Zitat Ilic IR, Djordjevic NP, Randjelovic PJ, Stojanovic NM, Radulovic NS, Ilic RS. Seven-year survey of classical and pleomorphic invasive lobular breast carcinomas in women from southeastern Serbia: differences in clinicopathological and immunohistochemical features. J BUON. 2016;21(5):1113–20.PubMed Ilic IR, Djordjevic NP, Randjelovic PJ, Stojanovic NM, Radulovic NS, Ilic RS. Seven-year survey of classical and pleomorphic invasive lobular breast carcinomas in women from southeastern Serbia: differences in clinicopathological and immunohistochemical features. J BUON. 2016;21(5):1113–20.PubMed
9.
Zurück zum Zitat Otsuru M, Aoki T, Kondo Y, Ota Y, Sasaki M, Suzuki T, et al. Salivary duct carcinoma with invasive micropapillary and rhabdoid feature arising in the submandibular gland. Tokai J Exp Clin Med. 2017;42(1):30–6.PubMed Otsuru M, Aoki T, Kondo Y, Ota Y, Sasaki M, Suzuki T, et al. Salivary duct carcinoma with invasive micropapillary and rhabdoid feature arising in the submandibular gland. Tokai J Exp Clin Med. 2017;42(1):30–6.PubMed
10.
Zurück zum Zitat Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997–4013. https://doi.org/10.1200/JCO.2013.50.9984.CrossRefPubMed Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997–4013. https://​doi.​org/​10.​1200/​JCO.​2013.​50.​9984.CrossRefPubMed
12.
Zurück zum Zitat Loening T, Leivo I, Simpson RHW, Weinreb I. Intraductal carcinoma. In: El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. Lyon: International Agency for Research on Cancer; 2017. p. 170–171. Loening T, Leivo I, Simpson RHW, Weinreb I. Intraductal carcinoma. In: El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. Lyon: International Agency for Research on Cancer; 2017. p. 170–171.
14.
Zurück zum Zitat Okamura T, Tang XY, Saito Y, Suzuki Y, Masuda S, Tokuda Y. Pleomorphic lobular carcinoma with lipid-producing activity: a report of 2 cases. Tokai J Exp Clin Med. 2013;38(3):103–8.PubMed Okamura T, Tang XY, Saito Y, Suzuki Y, Masuda S, Tokuda Y. Pleomorphic lobular carcinoma with lipid-producing activity: a report of 2 cases. Tokai J Exp Clin Med. 2013;38(3):103–8.PubMed
16.
Zurück zum Zitat Biggs PJ, Garen PD, Powers JM, Garvin AJ. Malignant rhabdoid tumor of the central nervous system. Hum Pathol. 1987;18(4):332–7.CrossRef Biggs PJ, Garen PD, Powers JM, Garvin AJ. Malignant rhabdoid tumor of the central nervous system. Hum Pathol. 1987;18(4):332–7.CrossRef
Metadaten
Titel
Signet Ring Cell Differentiation in Salivary Duct Carcinoma with Rhabdoid Features: Report of Three Cases and Literature Review
verfasst von
Mayumi Akaki
Akira Ishihara
Kentaro Nagai
Hidekazu Naono
Kenichi Taguchi
Hidetaka Yamamoto
Hiroyuki Tanaka
Hiroaki Kataoka
Publikationsdatum
02.06.2020
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2021
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-020-01186-4

Weitere Artikel der Ausgabe 1/2021

Head and Neck Pathology 1/2021 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …